Fundz

Cyclacel Pharmaceuticals, Inc. reported raising $7 Million in an initial SEC Form D filing, from an offering of $7 Million

PUBLIC · BGMSJan 04, 2021

Amount Raised

$7 Million

$7 Million sold, per SEC Form D (first sale Jan 4, 2021)

Round Type

Venture

Berkeley HeightsBiotechnologyTherapeuticsPharmaceuticalBiopharma

Quick answer

Bio Green Med Solution, Inc. raised $7 Million in a funding round, dated January 4, 2021. Bio Green Med Solution, Inc. is based in Berkeley Heights, New Jersey, United States.

How much did Bio Green Med Solution, Inc. raise?
Bio Green Med Solution, Inc. raised $7 Million in a funding round on January 4, 2021.
What does Bio Green Med Solution, Inc. do?
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis biology.
Where is Bio Green Med Solution, Inc. based and how big is it?
Bio Green Med Solution, Inc. is based in Berkeley Heights, New Jersey, United States. Fundz records about 13 employees.
Who are the decision-makers at Bio Green Med Solution, Inc?
Fundz holds 2 contacts at Bio Green Med Solution, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Bio Green Med Solution, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Oragenics raised $21M (Series C) on February 12, 2021.
  • Day One Biopharmaceuticals raised $130M (Series B) on February 10, 2021.
  • ISOThrive raised $5.2M on February 5, 2021.
  • Terns Pharmaceuticals raised $98M on January 7, 2021.
  • Parabilis Medicines raised $23M on January 5, 2021.
  • Terns Pharmaceuticals raised $87M (Series C) on January 5, 2021.

Who to call at Bio Green Med Solution, Inc., and when

A new round usually means Bio Green Med Solution, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bio Green Med Solution, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bio Green Med Solution, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bio Green Med Solution, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bio Green Med Solution, Inc.

Location

200 CONNELL DRIVE, SUITE 1500

Berkeley Heights, New Jersey, United States

About

Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis biology. The Company's strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bio Green Med Solution, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Bio Green Med Solution, Inc.'s next move

See what Strategic adds

Bio Green Med Solution, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.